A study in Taiwan, China, also indicated that 45% of PTB patients had elevated serum CA-125 levels prior to treatment and that serum CA-125 levels decrease with improvements in anti-TB treatment outcomes [4]. The gene discussed is MUC16; the disease is tuberculosis.